Open-label Study to Assess the Safety and Efficacy of TRP-8802 [Psilocybin] With Psychotherapy in Adult Participants With Fibromyalgia

Sponsor: TRYP Therapeutics
Recruitment Status: Not yet recruiting
First Posted: November 19, 2021

~

Molecular Insights into Psychedelic Drug Action (Slocum et al.)

Published: Nov 19, 2021
Journal of Neurochemistry

~

Psychedelic therapy’s Transdiagnostic effects: A Research Domain Criteria (RDoC) Systems Perspective (Kelly et al.)

Provisionally accepted: Nov 19, 2021
Frontiers in Psychiatry